This inventor holds 1 USPTO granted patent. Top assignee: Solvay Pharmaceuticals, Gmbh. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Matthias Mentzel: Innovator in Pharmaceutical Chemistry
Introduction
Matthias Mentzel is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that target specific receptors in the human body.
Latest Patents
Mentzel holds a patent for "Hydronopol derivatives as agonists on human ORL1 receptors." This invention pertains to a group of hydronopol derivatives that act as agonists on human ORL1 (nociceptin) receptors. The patent also covers the preparation of these compounds, pharmaceutical compositions containing a pharmacologically active amount of at least one of these novel hydronopol derivatives, and their use in treating disorders associated with ORL1 receptors.
Career Highlights
Matthias Mentzel is currently employed at Solvay Pharmaceuticals GmbH, where he continues to advance his research and development efforts. His work focuses on creating innovative solutions that can improve patient outcomes through targeted therapies.
Collaborations
Mentzel collaborates with esteemed colleagues, including Dania B Reiche and Reinhard Brückner, to further enhance the impact of his research in the pharmaceutical industry.
Conclusion
Matthias Mentzel's contributions to pharmaceutical chemistry, particularly through his patent on hydronopol derivatives, highlight his role as an innovator in the field. His ongoing work at Solvay Pharmaceuticals GmbH continues to pave the way for advancements in medical treatments.